Staphylococcus aureus testing sales will expand through 2036, with the coagulase test holding a 41.0% share in 2026 as the leading test type segment. Pharmaceutical applications lead with a 36.0% share. The market is expected to reach USD 4.79 billion in 2026 and USD 8.03 billion by 2036.